Companies that Ward Off ESG and Reputation Crises See Value Surge

$APO
$CVS
$FB
$JNJ
Investment Managers
Finance
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Get the next $APO alert in real time by email

PITTSBURGH, March 8, 2022 /PRNewswire-PRWeb/ -- Companies with ESG and reputational risk protection strategies have seen their stock prices rise 5% above the market within two weeks of a reputational challenge, and that premium is almost double for companies that have publicly shared and validated those strategies.

The study, by Steel City Re, an ESG and reputation insurer, also found that stock prices of firms that managed, validated and publicized ESG and reputation risk management strategies on average gained 9.3% over the subsequent seven months after a precipitating event, while firms in which such processes were in assumed by shareholders to be in place gained 4.3%. Companies that failed to institute, validate, and communicate risk management strategies lost 13.2% of their stock value over those seven-month periods, and they underperformed their peers by an average of 23.3%.

"Investors appear to reward firms that actively manage reputational risks as operational strategies and not just potential PR problems," said Nir Kossovsky, Steel City Re's CEO. "Our study makes the case for ESG-focused firms to take a more structured, substantive and comprehensive approach to risk governance and management."

"The data show that instituting, validating, and communicating risk management strategies can both fulfill the goals of stakeholder-centrism and meet shareholder expectations," he added.

Illustrative highlights include:

  • Johnson & Johnson (NYSE:JNJ) outperformed the market by 16% ($1.7bn) when its much publicized strategic supply chain security and product safety processes were proven effective in 1986.
  • Rolls Royce (OTC:RYCEY), whose board defined its risk governance mission as protecting the reputation, viability, and profitability of the firm, outperformed the market by 14.9% ($3.4bn) after it proved the quality of its safety controls throughout its supply chain in 2011.
  • Apollo Global Management (NYSE:APO) outperformed the market by 16.6% ($1.9bn) after it announced an ESG-focused governance reorganization and presented in 2021 and independent validation of a 3-year investment in reputation risk management.
  • CVS (NYSE:CVS) outperformed the market by 9.3% ($8.6bn) when, presciently anticipating the ESG movement, it pursued an ethical innovative strategy that shunned tobacco products in 2014. It outperformed rivals Walgreens (NYSE:WBA) and Rite Aid (NYSE:RAD) by 16.6% and 24.8% respectively.
  • Apple (NADQ:AAPL) outperformed the market by 24% ($505bn) after introducing innovative ethical privacy features that addressed a critical ESG concern in the technology sector in 2021. It outperformed Meta (NYSE:FB), facing a range of privacy challenges, by 34.9%.

About the Study

The Steel Re study looked at seven firms that took direct action to publicize their reputation risk management and governance, 20 firms whose protection strategies were in assumed by shareholders to be in place because of their response to external events, 20 firms whose strategies were shown to be insufficient over seven months, and from among these, 22 firms whose reputational impairment and value losses were measured against peer competitors.

The reputational challenges were all public events over the past 15 years supplemented by iconic cases of Johnson & Johnson's two Tylenol-related safety events of the 1980's. Individual gains and losses were calculated after normalizing for changes in the S&P500, and the date for ESG and reputational events was determined by a marked surge in stakeholder interest as explored in a related Steel City Re white paper.

About Steel City Re

Steel City Re provides parametric ESG insurance, reputational insurance and helps guide companies' boards and senior leadership in developing enhanced risk governance and management practices. Its underwriting model is supported by more than 7.3 million measures of reputational value and traditional financial metrics that also fuel ESG-focused hedge fund strategies. Its risk governance and management models are informed by principles of behavioral economics.

Media Contact

Desiree Niccoli, Steel City Re, 412-804-8649, desiree@alschulerpr.com

Steve Alschuler, Steel City Re, 917-647-2151, steve@alschulerpr.com

 

SOURCE Steel City Re

Get the next $APO alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$APO
$CVS
$FB
$JNJ

CompanyDatePrice TargetRatingAnalyst
2/13/2025$55.00 → $75.00Market Perform → Outperform
Leerink Partners
2/12/2025Neutral → Overweight
Cantor Fitzgerald
1/30/2025Hold → Buy
Edward Jones
12/10/2024$166.00Neutral
BofA Securities
12/3/2024$66.00Hold → Buy
Deutsche Bank
11/19/2024$188.00Overweight
Piper Sandler
11/18/2024$60.00 → $66.00Equal Weight → Overweight
Wells Fargo
11/15/2024$190.00Outperform
Wolfe Research
More analyst ratings

$APO
$CVS
$FB
$JNJ
Press Releases

Fastest customizable press release news feed in the world

See more
  • Apollo Announces 2025 Annual Meeting of Stockholders

    NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE:APO) today announced that its 2025 Annual Meeting of Stockholders will be held virtually on June 6, 2025, at 9:30 am ET. The record date for the meeting is April 14, 2025. Information on the virtual meeting will be included in the 2025 proxy statement. About ApolloApollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clie

    $APO
    Investment Managers
    Finance
  • Tenneco Announces Strategic Investment to Accelerate Growth

    NORTHVILLE, Mich., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Tenneco, Inc. ("Tenneco") today announced a strategic investment from Apollo Fund X into the company's Clean Air and Powertrain businesses – an important step in unlocking growth opportunities and strengthening the company's long-term position as a leading global automotive supplier. American Industrial Partners, a leading industrial-focused private equity firm with a strong track record in manufacturing and automotive, will invest alongside Apollo Fund X. Tenneco will continue to operate as one company with no changes to the management team and structure, operational cadence, or strategic priorities. This access to capital will enhance

    $APO
    Investment Managers
    Finance
  • Apollo to Acquire Bridge Investment Group

    Scaled Investment Platform Expands Apollo's Origination Capabilities in Residential and Industrial Real Estate Bridge Manages $50 Billion of High-Quality AUM in Complementary Sectors Aligned with Apollo's Long-Term Growth Strategy NEW YORK and SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE:APO) and Bridge Investment Group Holdings Inc. (NYSE:BRDG) ("Bridge" or the "Company") today announced they have entered into a definitive agreement for Apollo to acquire Bridge in an all-stock transaction with an equity value of approximately $1.5 billion. Founded in 2009, Bridge is an established leader in residential and industrial real estate as well as other specialized real

    $APO
    $BRDG
    Investment Managers
    Finance

$APO
$CVS
$FB
$JNJ
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$APO
$CVS
$FB
$JNJ
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$APO
$CVS
$FB
$JNJ
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$APO
$CVS
$FB
$JNJ
FDA approvals

Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

See more
  • September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

    For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

    $WBA
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • July 21, 2023 - FDA Roundup: July 21, 2023

    For Immediate Release: July 21, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA Center for Tobacco Products (CTP) announced that the center will host a virtual listening session on Aug. 22, 2023. During this listening session, CTP is requesting feedback on the development of a new 5-year strategic plan for the center, includin

    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care
  • May 5, 2022 - Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals

    For Immediate Release: May 05, 2022 Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not

    $JNJ
    Biotechnology: Pharmaceutical Preparations
    Health Care

$APO
$CVS
$FB
$JNJ
Leadership Updates

Live Leadership Updates

See more
  • InvestCloud Announces Founding Partnership with Apollo Enabling Groundbreaking Private Markets Account™ Network for Integrated Management of Public and Private Markets Assets

    InvestCloud to enable multiple service providers across the InvestCloud PMA Network to seamlessly access the full suite of capabilities to manage alternative investments on InvestCloud APL, a market-leading managed account platform with more than $3 trillion of assets on the platform Apollo to provide private markets model portfolios enabling a financial advisor's preferred portfolio construction – including fixed income, equity and real asset private market replacement solutions, risk-based portfolios and outcome-based solutions – across the InvestCloud platform InvestCloud, a global leader in wealth technology, today announced a founding partnership with Apollo (NYSE:APO) to activate th

    $APO
    Investment Managers
    Finance
  • GeminiBio Appoints Mike Stella to Board

    Strengthening Board with Industry Veterans Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based healthcare private equity firm, announced today the appointment of Michael Stella to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218608576/en/Mike Stella, CEO of Ascend Advanced Therapies, joins the Board at GeminiBio to provide strategic leadership in the fields of cell and gene therapy contract development and manufacturing. (Photo: Business Wire) GeminiBio prov

    $AMGN
    $GSK
    $JNJ
    $MRK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components
  • Guidewire Software Set to Join S&P MidCap 400; Arrowhead Pharmaceuticals to Join S&P SmallCap 600

    NEW YORK, Jan. 22, 2025 /PRNewswire/ -- Guidewire Software Inc. (NYSE:GWRE) will replace Arrowhead Pharmaceuticals Inc. (NASD: ARWR) in the S&P MidCap 400, and Arrowhead Pharmaceuticals will replace Barnes Group Inc. (NYSE:B) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, January 27. S&P 500 constituent Apollo Global Management Inc. (NYSE:APO) is acquiring Barnes Group in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector January 27, 2025 S&P MidCap 400 Addition Guidewi

    $APO
    $ARWR
    $B
    $GWRE
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care

$APO
$CVS
$FB
$JNJ
Financials

Live finance-specific insights

See more
  • Apollo to Acquire Bridge Investment Group

    Scaled Investment Platform Expands Apollo's Origination Capabilities in Residential and Industrial Real Estate Bridge Manages $50 Billion of High-Quality AUM in Complementary Sectors Aligned with Apollo's Long-Term Growth Strategy NEW YORK and SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE:APO) and Bridge Investment Group Holdings Inc. (NYSE:BRDG) ("Bridge" or the "Company") today announced they have entered into a definitive agreement for Apollo to acquire Bridge in an all-stock transaction with an equity value of approximately $1.5 billion. Founded in 2009, Bridge is an established leader in residential and industrial real estate as well as other specialized real

    $APO
    $BRDG
    Investment Managers
    Finance
  • CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2024 RESULTS

    Fourth Quarter Highlights Total revenues increased to $97.7 billion, up 4.2% compared to prior yearGAAP diluted EPS of $1.30 and Adjusted EPS of $1.19Full-Year Highlights Total revenues increased to $372.8 billion, up 4.2% compared to prior yearGAAP diluted EPS of $3.66 and Adjusted EPS of $5.42Generated cash flow from operations of $9.1 billion2025 Full-Year Guidance GAAP diluted EPS guidance range of $4.58 to $4.83Adjusted EPS guidance range of $5.75 to $6.00Cash flow from operations guidance of approximately $6.5 billionCEO Commentary"Our integrated model allows us to uniquely deliver a simpler, connected experience that saves time, saves money, and improves health. We have continued to s

    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
  • Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

    Transaction Highlights Walgreens Boots Alliance announces early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of an aggregate 6.1 million shares Concurrent with the early settlement, the Company executed a sale of the remaining 1.3 million shares of Cencora pledged under the early settled contracts. The Company receives approximately $300 million from the early settlement and the concurrent sale of shares Following today's early settlement, the Company owns approximately 12.6 million shares of Cencora pledged under the remaining prepaid variable share forward contracts, which have the potential to provide additional

    $COR
    $WBA
    Other Pharmaceuticals
    Health Care
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$APO
$CVS
$FB
$JNJ
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more